about
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesNeuroprotective Transcription Factors in Animal Models of Parkinson DiseaseNeuronal endoplasmic reticulum stress in axon injury and neurodegenerationPropagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Magnetic resonance imaging (MRI) to study striatal iron accumulation in a rat model of Parkinson's diseaseMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesNeuroimaging of Parkinson's disease: Expanding views.Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's diseaseSelenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's DiseaseMitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and ParkinAxon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicitySeverely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's diseaseDopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.Resting-state functional brain networks in Parkinson's disease.Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons.Naringin: a protector of the nigrostriatal dopaminergic projection.Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.AxonQuant: A Microfluidic Chamber Culture-Coupled Algorithm That Allows High-Throughput Quantification of Axonal Damage.Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease.Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brainTranscription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectivePresynaptic effects of levodopa and their possible role in dyskinesia.Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons.Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons in vivoCRMP4 and CRMP2 Interact to Coordinate Cytoskeleton Dynamics, Regulating Growth Cone Development and Axon ElongationInvolvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the PhenotypePrevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolismIn vivo characterization of the connectivity and subcomponents of the human globus pallidusIdentification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease.Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons.TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance.Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian PoisonsIGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neuronsPurkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains.
P2860
Q26747508-12A0E043-1C1A-49F6-9FF0-A2BD1B2D5C66Q26765693-31B61D2E-5453-416B-843C-71BCD12D905DQ26826912-812986F3-3796-47CB-ACF6-72AD52138CACQ27322513-C179E66D-72B7-4FA3-84A2-1C2B39066042Q27325407-22D167B3-BFD3-4089-9060-CA20C7F7FE8EQ28066691-1FE88927-059F-40AB-8A52-C62AAAE7184DQ28387732-73BAAAA2-719D-43BE-B72A-0B170AB88D6CQ28511558-11DF7EFF-45A7-4BFA-AAFA-96F09A589AEDQ28854286-FEF438E5-65D3-4AF8-BB1C-FC2C22F90449Q30273805-A5C2E49B-4E3F-4CA9-AC8C-C78EAF3A4CE9Q30577415-AF3CFAA3-2F1C-4587-BE80-BBE316C99BEEQ30795299-870FD4C6-72FC-460C-B6B8-7729DB6403F8Q30833636-28798813-BEFF-49EB-B44A-5EC9EDE29832Q30844298-915D883F-26C6-4C96-8F72-47689D8A4501Q30983855-1CEA2DA4-1AB7-428B-98B0-B6AA2ADF0C03Q31109638-37181010-7FA5-428B-BF1E-7EA7C12E1EDFQ33593180-63758456-D896-48F6-B092-8DBCD1FA7992Q33787324-212345B2-8484-47E6-A1A4-802F57E97FA6Q33819127-B69736E3-A001-49CB-BD47-276E7399B454Q33922530-953667E4-C035-4A5F-B954-24360C07E6F7Q34105588-44821F2B-5776-414A-A419-358B28CC38FFQ34159183-AE40DBD2-8A04-47A1-8F59-AEB240740187Q34287848-C3351B7F-2E1E-4588-A6E5-1EEFEBA92722Q34319584-03115FAF-94A0-498B-9A7F-CCC087430BCCQ35024695-B709C7FC-F26C-4123-A4A8-13EA2F2C9266Q35040280-C5391E94-850C-4ACB-BD08-46EE72F6D2B7Q35046986-F41A022E-6FF6-42CE-AC66-CE0F91FD8307Q35172603-41EC3002-2710-4A24-AD7D-BFC4096A5674Q35180062-D507A89B-5F6F-408D-BFBF-2CBB9CCE8809Q35639541-CA2C644A-5CF5-4781-A3E6-CD730F80DE33Q35819324-8DBC4FD0-6377-40B5-B9B7-AAF61F983957Q35978121-F3F2D51F-9EAB-4ED2-902A-E44C27F9F7F3Q36108993-25D46729-FCE6-4F39-85B8-5F7C44E5EA2AQ36109874-23E7A245-9B99-447A-AD3C-6602B5C59158Q36293826-9C828BC0-E482-4471-9DEB-8DD7AB58F648Q36840516-5094E3C6-F871-48DE-86C6-57036B3EA426Q36935441-46C643D2-3DE7-4098-9370-2356DBE7F6E3Q36971278-A91CEE26-2104-4ED8-BADD-C3DE9030027EQ37142863-5D3D7702-211D-450F-BD4F-71301B19E2A8Q37200329-9575CA6B-63DE-412E-B816-7CD2F211FCAD
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Axon degeneration in Parkinson's disease
@ast
Axon degeneration in Parkinson's disease
@en
type
label
Axon degeneration in Parkinson's disease
@ast
Axon degeneration in Parkinson's disease
@en
prefLabel
Axon degeneration in Parkinson's disease
@ast
Axon degeneration in Parkinson's disease
@en
P2860
P1476
Axon degeneration in Parkinson's disease
@en
P2093
Karen O'Malley
P2860
P356
10.1016/J.EXPNEUROL.2012.01.011
P407
P577
2012-01-18T00:00:00Z